FAM HIV-1 tat Protein (47-57)

Product Name
FAM HIV-1 tat Protein (47-57)
Product Quantity
1 mg

Product Description

This is the most characterized fragment of the HIV transactivator protein (TAT) YGRKKRRQRRR. The TAT peptide is rich in positively charged amino acids, notably arginine and lysine, which enable it to interact with negatively charged components of the cell membrane. This interaction facilitates its internalization into cells, primarily through endocytosis, although direct translocation mechanisms have also been proposed.

The conjugation of the TAT peptide with a fluorescent dye, such as 5(6)-carboxyfluorescein (FAM), results in FAM-YGRKKRRQRRR, a fluorescently labeled CPP. This modification allows researchers to visually track the peptide's cellular uptake and distribution using fluorescence-based techniques.

  • Applications:

    • Cellular Imaging: FAM-TAT enables real-time visualization of peptide internalization and intracellular trafficking.

    • Quantitative Uptake Studies: Fluorescence intensity measurements facilitate the quantification of peptide uptake in different cell types.

    • Cargo Delivery Tracking: When conjugated to therapeutic agents, FAM-TAT allows monitoring of cargo delivery efficiency.

  • Advantages:

    • Non-Invasive Monitoring: Fluorescence labeling permits non-destructive observation of live cells.

    • High Sensitivity: FAM's strong fluorescence provides sensitive detection of peptide localization.

  • Considerations:

    • Photobleaching: FAM is prone to photobleaching, which can affect long-term imaging studies.

    • pH Sensitivity: The fluorescence intensity of FAM can be influenced by pH changes, potentially impacting quantitative analyses.

Catalog Number
LT6137
Molecular Weight
1918.16
Formula
C85H128N32O20
Sequence
{FAM}-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg, {FAM}-YGRKKRRQRRR

We have a list of in-stock CPPs ready to conjugate with your targets. Your target can be a peptide, protein, fluorescent dye, or nanoparticle. Click for a full list of Cell Permeable Peptides.

Antennapedia Peptide RQIKIWFQNRRMKWKK;
C(Npys)-RQIKIWFQNRRMKWKK;
C-RQIKIWFQNRRMKWKK;
RQIKIWFQNRRMKWKK-C;
In Stock
Penetratin
(GG linker)
RQIKIWFQNRRMKWKK-GG;
C-RQIKIWFQNRRMKWKK-GG;
RQIKIWFQNRRMKWKK-GG-C;
In Stock
Penetratin
and Labeled Antennapedia peptides
RQIRIWFQNRRMRWRR;
C-RQIRIWFQNRRMRWRR;
{FITC-LC}-RQIKIWFQNRRMKWKK;
{5-FAM}-RQIKIWFQNRRMKWKK;
{Cy3}-RQIKIWFQNRRMKWKK;
{Cy5}-RQIKIWFQNRRMKWKK;
{Alexa488}-RQIKIWFQNRRMKWKK;
In Stock
(Arg)9 Oligomer peptides
Fluorescent Labeling
Stearyl-R8;
FITC-Stearyl-R8;
RRRRRRRRRC;
C(Npys)RRRRRRRRR;
HS-cR10: C-(mini-PEG)-(mini-PEG)-KRrRrRrRrRrE;
C(Npys)rrrrrrrrr, r is D amino acid;
{FAM}-RRRRRRRRR;
{TAMRA}-RRRRRRRRR;
{Biotin}-RRRRRRRRR;
{Cy Dyes}-RRRRRRRRR;
{Alexa Dyes}-RRRRRRRRR;
In Stock
TAT (47-57)
and Variants
YGRKKRRQRRR ;
C-YGRKKRRQRRR;
VSRRRRRRGGRRRR;
YGRKKRRQRRR-C;
{Biotin}-YGRKKRRQRRR;
{FAM}-YGRKKRRQRRR;
{TAMRA}-YGRKKRRQRRR;
YGRKKRRQRRRGGGC(Npys);
C(Npys)YGRKKRRQRRR-K(FAM);
MDYKDHDGDYKDHDIDYKDDDDK;
In Stock
TAT GluR23 variants
TAT-NSF222 Fusion Peptide
TAT-NSF700 Fusion Peptide
HIV-1 Tat (48-60)
YGRKKRRQRRR;
YGRKKRRQRRRYKEGYNVYG;
YGRKKRRQRRRVYKYGGYNE;
YGRKKRRQRRRAKEGANVAG;
YGRKKRRQRRR GGG LDKEFNSIFRRAFASRVFPPE;
YGRKKRRQRRR GGG ENSFRFLADIFPAKAFPVRFE;
YGRKKRRQRRR GGG LLDYVPIGPRFSNLVLQALLVL;
YGRKKRRQRRR GGG IPPVYFSRLDLNLVVLLLAQL;
GRKKRRQRRRPPQ;
Cy3-GISYGRKKRRQRRRAHQ;
(5-FAM)-GISYGAKKRRQRRRAHQ-Cys(TAMRA);
Cys-GRKKRRQRRRPPQ;
GRKKRRQRRRPPQC;
Cys-GRKKRRQRRR;
RRRQRRKKRGGDIMGEWGNEIFGAIAGFLG;
YGRKKRRQRRRKLSSIESDV;
Crude Peptide In Stock,
HPLC Purify in 5 Days
Cell Permeable-Mastoparan Peptide
NGR peptide, Aminopeptidase N Ligand (CD13)
NGR Peptide 1
Anti-BetaGamma (MPS-Phosducin-like protein C terminus)
Buforin 2
Rabies Virus Glycoprotein (RVG)
Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R)
IKKgamma NEMO Binding Domain (NBD) Inhibitory Peptide
KALA
NF-kB Inhibitor, SN50
pVEC (Cadherin-5)
SV40 Large T-antigen Nuclear Localization Signal (NLS)
SV40 Large T-antigen Nuclear Localization Signal (NLS) derived peptide
SV40 Large T-antigen Nuclear Localization Signal (NLS) Analog
TfR Targeting Peptide
Transdermal Peptide
Transportan
Pep-1
Pep-1-Cysteamine
cardiac targeting peptide (CTP)

INLKALAALAKKIL-NH2;
CNGRCG (Disulfide bridge: 1-5);
CNGRCGGklaklakklaklak-NH2 (Disulfide bridge: 1-5);
AAVAL LPAVL LALLA VTDQL GEDFF AVDLE AFLQE FGLLP EKE;
TRSSRAGLQFPVGRVHRLLRK;
YTIWMPENPRPGTPCDIFTNSRGKRASNG;
YTIWM PENPR PGTPC DIFTN SRGKR ASNGG GGRRR RRRRR R;
DRQIKIWFQNRRMKWKKTALDWSWLQTE;
WEAKLAKALAKALAKHLAKALAKALKACEA;
AAVALLPAVLLALLAPVQRKRQKLMP;
LLIILRRRIRKQAHAHSK;
PKKKRKVEDPYC;
CGGGPKKKRKVED;
CGYGPKKKRKVGG
THRPPMWSPVWP;
ACSSSPSKHCG;
GWTLNSAGYLLGKINLKALAALAKKIL;
KETWWETWWTEWSQPKKKRKV;
Ac-KETWWETWWTEWSQPKKKRKV-cysteamine;
APWHLSSQYSRT

Crude Peptide In Stock,
HPLC Purify in 5 Days
  • 5 Units in Stock
Ask a Question

$350.00

Add to Cart: